Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

844 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
New advances in the treatment of generalized anxiety disorder: the multimodal antidepressant vortioxetine.
Orsolini L, Tomasetti C, Valchera A, Iasevoli F, Buonaguro EF, Vellante F, Fornaro M, Fiengo A, Mazza M, Vecchiotti R, Perna G, de Bartolomeis A, Martinotti G, Di Giannantonio M, De Berardis D. Orsolini L, et al. Among authors: mazza m. Expert Rev Neurother. 2016 May;16(5):483-95. doi: 10.1586/14737175.2016.1173545. Epub 2016 Apr 18. Expert Rev Neurother. 2016. PMID: 27050932 Review.
A comprehensive review on the efficacy of S-Adenosyl-L-methionine in Major Depressive Disorder.
De Berardis D, Orsolini L, Serroni N, Girinelli G, Iasevoli F, Tomasetti C, de Bartolomeis A, Mazza M, Valchera A, Fornaro M, Perna G, Piersanti M, Di Nicola M, Cavuto M, Martinotti G, Di Giannantonio M. De Berardis D, et al. Among authors: mazza m. CNS Neurol Disord Drug Targets. 2016;15(1):35-44. doi: 10.2174/1871527314666150821103825. CNS Neurol Disord Drug Targets. 2016. PMID: 26295824 Review.
Inflammatory markers and suicidal attempts in depressed patients: A review.
Marini S, Vellante F, Matarazzo I, De Berardis D, Serroni N, Gianfelice D, Olivieri L, Di Renzo F, Di Marco A, Fornaro M, Orsolini L, Valchera A, Iasevoli F, Mazza M, Perna G, Martinotti G, Di Giannantonio M. Marini S, et al. Among authors: mazza m. Int J Immunopathol Pharmacol. 2016 Dec;29(4):583-594. doi: 10.1177/0394632015623793. Epub 2016 Jan 4. Int J Immunopathol Pharmacol. 2016. PMID: 26729403 Free PMC article. Review.
The Novel Antipsychotic Cariprazine (RGH-188): State-of-the-Art in the Treatment of Psychiatric Disorders.
De Berardis D, Orsolini L, Iasevoli F, Prinzivalli E, de Bartolomeis A, Serroni N, Mazza M, Valchera A, Fornaro M, Vecchiotti R, Carano A, Sepede G, Vellante F, Matarazzo I, Pompili M, Perna G, Conti C, Segura-García C, Martinotti G, Di Giannantonio M. De Berardis D, et al. Among authors: mazza m. Curr Pharm Des. 2016;22(33):5144-5162. doi: 10.2174/1381612822666160701084447. Curr Pharm Des. 2016. PMID: 27396597 Review.
Effect of agomelatine treatment on C-reactive protein levels in patients with major depressive disorder: an exploratory study in "real-world," everyday clinical practice.
De Berardis D, Fornaro M, Orsolini L, Iasevoli F, Tomasetti C, de Bartolomeis A, Serroni N, De Lauretis I, Girinelli G, Mazza M, Valchera A, Carano A, Vellante F, Matarazzo I, Perna G, Martinotti G, Di Giannantonio M. De Berardis D, et al. Among authors: mazza m. CNS Spectr. 2017 Aug;22(4):342-347. doi: 10.1017/S1092852916000572. Epub 2016 Oct 5. CNS Spectr. 2017. PMID: 27702411
Affective temperaments are associated with specific clusters of symptoms and psychopathology: a cross-sectional study on bipolar disorder inpatients in acute manic, mixed, or depressive relapse.
Iasevoli F, Valchera A, Di Giovambattista E, Marconi M, Rapagnani MP, De Berardis D, Martinotti G, Fornaro M, Mazza M, Tomasetti C, Buonaguro EF, Di Giannantonio M, Perugi G, de Bartolomeis A. Iasevoli F, et al. Among authors: mazza m. J Affect Disord. 2013 Nov;151(2):540-550. doi: 10.1016/j.jad.2013.06.041. Epub 2013 Jul 12. J Affect Disord. 2013. PMID: 23856282
Treatment of antipsychotic-induced hyperprolactinemia: an update on the role of the dopaminergic receptors D2 partial agonist aripiprazole.
De Berardis D, Fornaro M, Serroni N, Marini S, Piersanti M, Cavuto M, Valchera A, Mazza M, Girinelli G, Iasevoli F, Perna G, Martinotti G, Di Giannantonio M. De Berardis D, et al. Among authors: mazza m. Recent Pat Endocr Metab Immune Drug Discov. 2014 Jan;8(1):30-7. doi: 10.2174/1872214807666131229125700. Recent Pat Endocr Metab Immune Drug Discov. 2014. PMID: 24372345 Review.
Efficacy and clinical determinants of antipsychotic polypharmacy in psychotic patients experiencing an acute relapse and admitted to hospital stay: results from a cross-sectional and a subsequent longitudinal pilot study.
Iasevoli F, Buonaguro EF, Marconi M, Di Giovambattista E, Rapagnani MP, De Berardis D, Martinotti G, Mazza M, Balletta R, Serroni N, Di Giannantonio M, de Bartolomeis A, Valchera A. Iasevoli F, et al. Among authors: mazza m. ISRN Pharmacol. 2014 Jan 27;2014:762127. doi: 10.1155/2014/762127. eCollection 2014. ISRN Pharmacol. 2014. PMID: 24592333 Free PMC article.
Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depression.
De Berardis D, Fornaro M, Serroni N, Campanella D, Rapini G, Olivieri L, Srinivasan V, Iasevoli F, Tomasetti C, De Bartolomeis A, Valchera A, Perna G, Mazza M, Di Nicola M, Martinotti G, Di Giannantonio M. De Berardis D, et al. Among authors: mazza m. Int J Mol Sci. 2015 Jan 5;16(1):1111-30. doi: 10.3390/ijms16011111. Int J Mol Sci. 2015. PMID: 25569089 Free PMC article. Review.
844 results